TY - JOUR AU - Terawaki, Yuichi AU - Nomiyama, Takashi AU - Akehi, Yuko AU - Takenoshita, Hiromasa AU - Nagaishi, Ryoko AU - Tsutsumi, Yoko AU - Murase, Kunitaka AU - Nagasako, Hisahiro AU - Hamanoue, Nobuya AU - Sugimoto, Kaoru AU - Takada, Ayako AU - Ito, Kenji AU - Abe, Yasuhiro AU - Sasatomi, Yoshie AU - Ogahara, Satoru AU - Nakashima, Hitoshi AU - Saito, Takao AU - Yanase, Toshihiko PY - 2013 DA - 2013/02/28 TI - The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis JO - Diabetology & Metabolic Syndrome SP - 10 VL - 5 IS - 1 AB - Although incretin therapy is clinically available in patients with type 2 diabetes undergoing hemodialysis, no study has yet examined whether incretin therapy is capable of maintaining glycemic control in this group of patients when switched from insulin therapy. In this study, we examined the efficacy of incretin therapy in patients with insulin-treated type 2 diabetes undergoing hemodialysis. SN - 1758-5996 UR - https://doi.org/10.1186/1758-5996-5-10 DO - 10.1186/1758-5996-5-10 ID - Terawaki2013 ER -